Evaluate quantum computing stocks by testing four things separately: what the company has actually demonstrated, whether customers are paying and returning, how much cash the business consumes, and what future growth its share price already assumes. A qubit count or ambitious roadmap is not proof of commercial advantage, and companies using different quantum architectures cannot be ranked reliably by qubit count alone. This is a diligence framework, not a live valuation or a recommendation to buy any particular stock.
Start with what the company does—and what kind of quantum computer it is building
First establish whether you are looking at a quantum-computing pure play or a diversified technology company with a quantum program. Quantum may be central to a pure play’s prospects, while it may have little effect on a larger company’s financial results. Then identify the architecture, products and services, and which parts of the business actually depend on quantum computing.
As an Amazon Associate I earn from qualifying purchases.
The public companies discussed here are not interchangeable. D-Wave describes superconducting annealing systems and also a gate-model effort. Rigetti describes a full-stack platform and cloud delivery. IonQ’s business includes quantum hardware, cloud access and related services. These descriptions come from their fiscal 2025 Form 10-K filings. A comparison should be architecture-aware rather than a leaderboard built from one headline metric.
Separate demonstrated results from targets
For each technical claim, record the metric, the workload and test conditions, the date, and who reported it. Ask whether a customer or independent result corroborates it. Keep a measured result separate from a management target, roadmap milestone or projection of future capability.
Qubit count alone leaves out important questions: how reliably operations are performed, how qubits connect, how errors are handled, how much of the system is available for useful work, and whether performance scales to a relevant workload. Control systems and error correction also affect whether a system can become useful beyond a laboratory demonstration. Compare like with like, and ask what problem the reported result solves better than available alternatives.
Test whether technical progress is turning into customer value
A technical milestone can attract attention without establishing a commercial advantage. Look for evidence that a customer has deployed the system, uses it repeatedly, and can identify a measurable outcome worth paying for. A pilot, research collaboration or development contract may demonstrate interest; it does not by itself show repeatable demand or scalable economics.
Read the revenue disclosures and management discussion, not just a year-over-year growth rate. Separate quantum-system sales, cloud usage, maintenance, software, consulting, development contracts, government work, acquisitions, and adjacent or unrelated businesses. For each source, consider whether it recurs, depends on milestones, is concentrated in a small number of customers, or relies on subsidies and partnerships. Check gross profit and cash collection alongside recognized revenue: booked sales are not the same as cash received, and revenue growth does not guarantee attractive margins.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minuteRank #2
How the business mixes differ
| Company | What its filing describes | What an investor should investigate |
|---|---|---|
| IonQ | Revenue sources include quantum-system design, development, construction and sales; maintenance and support; quantum-computing-as-a-service access; consulting; and satellite imagery and data. | How much revenue is directly quantum-related, which sources recur, and how the different lines contribute to margins and cash collection. |
| Rigetti | The substantial majority of current revenue comes from development contracts. The company expects those contracts to remain important for several years as it works to grow system and cloud-service sales. | Whether development work leads to repeat system or cloud purchases, and whether the mix becomes less dependent on contracts. |
| D-Wave | The company describes cloud access, professional services and system sales as revenue sources. | The relative contribution, recurrence and profitability of each source, and the customer demand behind them. |
These business descriptions are from the companies’ fiscal 2025 Form 10-K filings. They do not establish that the companies have equivalent revenue mixes or comparable commercial maturity.
Read revenue and losses together
Reported growth can be meaningful while the business remains far from self-funding. The figures below are company-reported fiscal-year results for years ended December 31, 2025 and 2024. They are not a normalized comparison: business mix, acquisition activity, accounting periods and revenue recognition can differ. Use audited statements and their notes before drawing comparisons.
| Company | 2025 revenue | 2024 revenue | 2025 loss figures | 2024 loss figures |
|---|---|---|---|---|
| D-Wave Quantum, 2026 Form 10-K | $24.6 million | $8.8 million | Operating loss: $100.4 million; net loss: $355.1 million | Operating loss: $77.2 million; net loss: $143.9 million |
| Rigetti Computing, 2026 Form 10-K | Not stated here; consult the filing | Not stated here; consult the filing | Net loss: $216.2 million | Net loss: $201.0 million |
The size of a net loss does not by itself explain the cash runway: non-cash charges and working-capital movements matter. Compare the income statement with cash-flow statements, cash balances, and share-count changes. D-Wave’s reported net loss was substantially larger than its operating loss in both years, so an investor should use the filing to understand the components rather than treating net loss as a direct measure of cash burned.
Check cash needs, dilution and execution risks
Early-stage technical companies can advance their systems while still needing additional capital. Review the latest filing for cash and equivalents, restricted cash, operating cash use, debt and convertible securities, stock-based compensation, warrants, capital commitments, acquisition spending, customer concentration and changes in shares outstanding. Estimate runway under at least a current-spending case and a higher-spending case; explain assumptions about research, manufacturing, hiring and sales rather than assuming spending remains constant.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Potential equity issuance can dilute existing shareholders. Debt or convertible financing brings different costs and risks. Neither technical progress nor a rising share price removes the need to assess financing terms and future capital requirements.
- Technical and scaling risk: milestones may be delayed, performance may not scale, or a system may not solve commercially relevant workloads.
- Competitive risk: other quantum architectures and improvements in classical computing may offer better economics for a given problem.
- Adoption risk: customers may be interested in experiments but unwilling to pay enough for recurring use.
- Business risk: revenue may depend on a few customers, development contracts, government support or partnerships.
- Financing risk: continuing losses may require capital raises that increase debt or dilute shareholders.
- Disclosure risk: forward-looking statements describe expectations, not guaranteed results. D-Wave’s 2025 Form 10-K cautions that actual results may differ materially from those anticipated.
Judge valuation with scenarios, not a single multiple
For a loss-making company, a revenue multiple is not a verdict. Consider enterprise value relative to current revenue and gross profit, then ask what revenue growth, margin improvement and market share would be required to support the valuation. A scenario model is more useful when it makes its assumptions visible and tests what happens if adoption is slower, a technical milestone is delayed, margins remain low, capital spending rises or new shares are issued.
Do not assume that a large forecast for the quantum-computing market will translate into revenue for one listed company. The commercial opportunity depends on which workloads become useful, which architecture serves them, whether customers pay, and what share a specific company can capture. A market-size estimate is not a company forecast.
Keep market excitement separate from business evidence
In an analysis published May 13, 2026, the European Securities and Markets Authority (ESMA) described repeated valuation surges and corrections since late 2024. It said the public pure-play companies remained at an early stage of commercialization and were operating at significant losses. ESMA reported that the combined market capitalization of four US-listed quantum companies temporarily exceeded $65 billion in late 2025, while their weekly trading volumes surpassed $70 billion. These are historical measures, not current valuations or price targets.
ESMA identified expectations of external funding, including government support, technical milestone announcements and projections of economic impact among catalysts associated with stock movements. Treat such events as prompts to check filings and customer evidence, not proof that an issuer has achieved a durable commercial advantage.
Best Value
ESMA also reported that generative AI startups raised approximately $25 billion in 2024 and $35 billion in 2025—about 20 times and eight times the amounts invested in quantum-computing startups in those respective years. That comparison describes relative startup funding, not the addressable market for quantum computing or the likely return on a quantum stock.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Compare ways to get exposure before choosing a security
Pure-play shares concentrate exposure in a small, technically and financially uncertain business. A diversified technology company may have quantum activity but other operations that dominate its financial results. A fund may spread holdings across issuers, but its mandate, concentration, fees, liquidity and actual holdings determine what exposure it provides. Check the current prospectus and holdings rather than relying on a fund’s name.
ESMA reported that the first three EU-domiciled ETFs with a specific quantum-computing focus launched in 2025 and together held $0.6 billion in assets under management at the end of March 2026. It also noted comparable US products, including a quantum-computing and machine-learning themed ETF and a recently launched pure-play quantum fund. These dated figures do not establish present availability, holdings or suitability; those vary by product and jurisdiction.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →A practical diligence checklist
- Define the exposure. Identify the issuer, its quantum architecture, its products, and whether quantum is central to its finances or one initiative within a diversified company.
- Record technical evidence. Write down demonstrated metrics, dates, test conditions and workload relevance. Label roadmap targets and projections separately, and seek customer or independent corroboration.
- Trace revenue to its source. Separate system sales, cloud access, services, development work, government contracts, acquisitions and adjacent businesses. Check recurrence, concentration, gross profit and cash collection.
- Measure funding needs. Review cash, cash use, debt, convertibles, commitments, compensation, warrants and share-count changes. Model runway under more than one spending assumption.
- Test the price against outcomes. Compare enterprise value with revenue and gross profit, then model adoption, margins, technical timing, capital spending and dilution under both favorable and adverse assumptions.
- Verify the latest information. Refresh filings, market prices, share counts and, for funds, prospectuses, fees and holdings. Historical market and ETF statistics should not be treated as current data.
Use later company filings and customer disclosures to check whether milestones and commercial claims were achieved. A sound evaluation keeps technical promise, commercial evidence, financial endurance and market expectations distinct until the evidence connects them.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
